Metastatic hormone-sensitive prostate cancer Clinical Trials

Delta Trials indexes 24 clinical trials for Metastatic hormone-sensitive prostate cancer in its publicly accessible dataset. Of these, 8 enrolling participants at this time and 9 trials have reached completion. This research takes place spanning 803 research sites around the world. An additional 7 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.